1.McGeer, A, Fleming, CA, Willey, B, Green, KA, Low, DE. Antimicrobial resistance in common hospital pathogens in Ontario. Ontario Medical Association, QMP-LS News 2007; No. 116. Available at: http://www.qmpls.org/pub_resources/publications/qmpls_news/pdf/qmplsnewsll6.pdf. Accessed October 20, 2007.
2.Noble, WC, Virani, Z, Cree, RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;72:195–198.
3.Appelbaum, PC. The emergence of vancomycin-intermediate and van-comycin-resistant Staphylococcus aureus. Clin Microbiol Infect 2006;12(suppl 1):16–23.
4.Zirakzadeh, A, Patel, R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 2006;81:529–36.
5.Byers, KE, Anglim, AM, Anneski, CJ, et al.A hospital epidemic of vancomycin-resistant enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140–147.
6.Bonten, MJ, Slaughter, S, Ambergen, AW, et al.The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127–1132.
7.Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995;44:1–13.
8.Stelfox, HT, Bates, DW, Redelmeier, DA. Safety of patients isolated for infection control. JAMA 2003;290:1899–1905.
10.Willey, BM, Jones, RN, McGeer, A, et al.Practical approach to the identification of clinically relevant Enterococcus species. Diagn Microbiol Infect Dis 1999;34:165–171.
11.NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: 5th ed. Approved standard M7-A5. Wayne, PA: NCCLS, 2000.
12.Ulrich, RS, Quan, X, Choudhary, R, Joseph, A, Zimring, C. Evidence-Based Design Research for Healthcare. 2004. Available at: http://www.health-design.org/research/reports/physical_environ.php. Accessed October 20, 2007.
13.Kibbler, CC, Quick, A, O'Neill, AM. The effect of increased bed numbers on MRSA transmission in acute medical wards. J Hosp Infect 1998;39:213–219.
14.Gastmeier, P, Schwab, F, Geifers, C, Ruden, H. To isolate or not to isolate? Analysis of data from the German Nosocomial Infection Surveillance System regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol 2004;25:109–113.
15.Mulin, B, Rouget, C, Clement, C, et al.Association of private isolation rooms with ventilator-associated Acinetobacter baumanii pneumonia in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1997;18:499–503.
16.Bhavnani, SM, Drake, JA, Forrest, A, et al.A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000;36:145–158.
17.Timmers, GJ, van der Zwet, WC, Simoons-Smit, IM, et al.Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol 2002;116:826–833.
18.Tacconelli, E, Karchmer, AW, Yokoe, D, et al.Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule. Clin Infect Dis 2004;39:964–970.
19.Wendt, C, Krause, C, Xander, LU, et al.Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany. J Hosp Infect 1999;42:193–200.
20.Carmeli, Y, Eliopoulos, GM, Samore, MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002;8:802–807.
21.D'Agata, EM, Gautam, S, Green, WK, et al.High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002;34:167–172.